The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.

about

The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.

Item

http://www.wikidata.org/entity/Q38781597

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The paradoxical changes of mem ...... tocellular carcinoma patients.

@en

type

Item

label

The paradoxical changes of mem ...... tocellular carcinoma patients.

@en

prefLabel

The paradoxical changes of mem ...... tocellular carcinoma patients.

@en

P1476

The paradoxical changes of mem ...... atocellular carcinoma patients

@en

P2093

Di Su

http://www.w3.org/2001/XMLSchema#string

Geng-Lin Zhang

http://www.w3.org/2001/XMLSchema#string

Liang Peng

http://www.w3.org/2001/XMLSchema#string

Xiang Zhu

http://www.w3.org/2001/XMLSchema#string

Zhan-Lian Huang

http://www.w3.org/2001/XMLSchema#string

Zhao-Xia Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway

A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator

BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination

Immune Checkpoint Blockade in Cancer Therapy

Global cancer statistics, 2002

Sorafenib in advanced hepatocellular carcinoma

High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases

Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway.

P304

1520-1524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JGH.13678

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Qiyi Zhao

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27987232

http://www.w3.org/2001/XMLSchema#string